Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,826.00    -2.00 (-0.07%)
Bid:
2,824.00
Ask:
2,828.00
Spread: 4.00 (0.142%)
Market Cap: £6.72b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Directorate Change

4 Nov 2024 11:52

RNS Number : 8376K
IMI PLC
04 November 2024
 

4 November 2024

Directorate Change

Luke Grant appointed Chief Financial Officer

 

IMI plc ("IMI" or the "Group"), the specialist engineering company, today announces the appointment of Luke Grant as Chief Financial Officer ("CFO") and Executive Director with effect from 25 July 2025.

 

Luke will succeed Daniel Shook who, in July 2024, announced his intention to step down for family reasons. After 10 years of service, Daniel will step down from the Board on 25 July 2025 and will remain available to the Group until the end of 2025 to support an orderly transition.

 

Luke has been with IMI for 11 years and is currently Vice President of Finance for the Industrial Automation sector. Prior to this, Luke was Group Financial Controller and Head of Investor Relations. He has also held senior finance positions within IMI's former Precision Engineering division, based in Germany. Luke spent the early part of his career working in the audit practice of EY. Full remuneration details will be disclosed in our 2024 Directors' Remuneration Report.

 

Lord Smith of Kelvin, Chair of IMI, commented:

"Luke is a highly respected member of our senior finance team and I am delighted that he will be joining the Board. His appointment demonstrates our robust succession planning and our ability to promote from within. On behalf of the Board, I would like to welcome him to his new role. We are enormously grateful to Daniel for his service to IMI, during which time he has played a vital role in creating the business we have today. Luke's promotion is testament to the strength of the finance function that Daniel has helped to build."

 

Roy Twite, Chief Executive Officer of IMI, said:

"It has been a privilege to work with Daniel over the last nine years. He has been a valued colleague providing support and counsel, and I wish him all the very best for the future. Luke is an outstanding successor. For more than a decade at IMI, he has demonstrated his financial expertise, global mindset and commitment to our culture. He has a deep knowledge of IMI and the drivers of its performance, which will ensure continuity as we continue to grow and improve the business."

 

Luke Grant, incoming Chief Financial Officer of IMI, added:

"I am honoured to be appointed as CFO of IMI. I have had the privilege of working in a variety of senior finance roles in my time with the Group, and I am excited about the opportunity to join the Board and the Executive Committee to capitalise on the opportunities we have ahead."

 

There are no matters that require disclosure under UKLR 6.4.8R.

 

For further information, please contact:

 

Louise Waldek Company Secretary Tel: 0121 717 3700

Matt Denham Headland Tel: +44 (0)7551 825 496

 

End.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZLFBZFLZFBK
Date   Source Headline
11th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20261:55 pmRNSDirector/PDMR Shareholding
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20264:55 pmRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 202610:19 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20264:28 pmRNSShare repurchase programme
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20264:38 pmRNSDirector/PDMR Shareholding
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20264:50 pmRNSDirectorate change
15th May 20269:12 amRNSDirector/PDMR Shareholding
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 202611:47 amRNSDirector/PDMR Shareholding
13th May 20267:00 amRNSTransaction in Own Shares
12th May 202611:53 amRNSResult of AGM
12th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTrading Update
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:10 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 202611:49 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.